Fremont, CA, United States of America

William W Xiang

This inventor holds 12 USPTO granted patents and 9 published patent applications and 2 EPO patents, primarily in Pharmaceutical Formulations. Top assignee: Xwpharma Ltd.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William W Xiang. Retrieved from https://idiyas.com/inventor/william-w-xiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmacokinetics
Controlled Release
Modified Release
Gamma-Hydroxybutyric Acid
Ketamine Derivatives
Water-Soluble Ingredients
Oral Dosage Forms
Granulations
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of William W. Xiang

Introduction

William W. Xiang, a prominent inventor based in Fremont, CA, has made significant strides in the field of pharmaceuticals. With a total of eight patents to his name, he has been instrumental in advancing drug formulations that include gamma-hydroxybutyric acid derivatives. His work has not only improved pharmaceutical compositions but also enhanced their pharmacokinetic properties.

Latest Patents

Xiang's latest patents include two innovative formulations aimed at the pharmacokinetics of combined release formulations of gamma-hydroxybutyric acid derivatives. The first patent focuses on pharmaceutical compositions that incorporate an immediate release component consisting of 4-((L-valyl)oxy)butanoic acid, along with a modified release component of the same compound. This formulation allows for effective oral administration, thereby improving therapeutic efficacy. The second patent presents modified release compositions utilizing pharmaceutical granulations, which feature a functional coating surrounding a core of 4-((L-valyl)oxy)butanoic acid. These coatings facilitate both immediate and modified release, thus making the pharmaceutical granulations suitable for oral compositions.

Career Highlights

William W. Xiang has established a distinguished career in pharmaceutical innovation at XWPharma Ltd. His expertise lies in developing efficacious pharmaceutical formulations that combine effectiveness with patient safety. His dedication to research and development has made his contributions invaluable to the field.

Collaborations

Throughout his career, Xiang has collaborated with talented colleagues, including Daniel M. Canafax and Sami Karaborni. These partnerships have been pivotal in driving the innovation process and enhancing the development of advanced pharmaceutical solutions.

Conclusion

In summary, William W. Xiang’s contributions to pharmaceutical sciences through his eight patents underscore the importance of innovation and collaboration in drug development. His work not only showcases his inventiveness but also reflects his commitment to improving health outcomes through advanced pharmaceutical formulations. As the landscape of medicine continues to evolve, inventors like Xiang are crucial in paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…